Mark Erlander

Insider Reports History

Entity
Individual
Location
C/O Trovagene, Inc., 11055 Flintkote Avenue, Suite A, San Diego, CA
Signature
/s/ Mark Erlander
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Erlander:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cardiff Oncology, Inc. Chief Executive Officer, Director Stock Options 2.17M $5.64M $2.60 Mar 7, 2024 Direct

Insider Reports Filed by Mark Erlander

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRDF Cardiff Oncology, Inc. Mar 7, 2024 1 $0 4 Mar 7, 2024 Chief Executive Officer, Director
CRDF Cardiff Oncology, Inc. Mar 15, 2023 1 $0 4 Mar 16, 2023 Chief Executive Officer, Director
CRDF Cardiff Oncology, Inc. Nov 25, 2022 1 $14.3K 4 Nov 29, 2022 Chief Executive Officer, Director
CRDF Cardiff Oncology, Inc. Mar 9, 2022 1 $0 4 Mar 10, 2022 Chief Executive Officer, Director
CRDF Cardiff Oncology, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Chief Executive Officer, Director